The company has launched Nebzmart® GFB Smartules® and Glenmark Airz® FB Smartules®, world’s first nebulised, fixed-dose triple therapy for the treatment of Chronic Obstructive Pulmonary Disease (COPD)The company has launched Nebzmart® GFB Smartules® and Glenmark Airz® FB Smartules®, world’s first nebulised, fixed-dose triple therapy for the treatment of Chronic Obstructive Pulmonary Disease (COPD) Latest News [ SOBAN NEWS: International and National ]